EcoDrugPlus

Casein Kinase 1 Epsilon

Ensembl ID : ENSPSNG00000004204
Gene Symbol: CSNK1E
3 Cross references
268 Possible Orthologues:

Casein Kinase 2 Alpha 1

Ensembl ID : ENSPSNG00000008081
Gene Symbol: CSNK2A1
2 Cross references
208 Possible Orthologues:

Caspase 1

Ensembl ID : ENSPSNG00000010097
Gene Symbol: CASP1
2 Cross references
451 Possible Orthologues:

Caspase 8

Ensembl ID : ENSPSNG00000017590
Gene Symbol: CASP8
3 Cross references
132 Possible Orthologues:

Caspase 9

Ensembl ID : ENSPSNG00000016214
Gene Symbol: CASP9
3 Cross references
202 Possible Orthologues:

Catechol-O-Methyltransferase

Ensembl ID : ENSPSNG00000022080
Gene Symbol: COMT
3 Cross references
275 Possible Orthologues:

Cathepsin C

Ensembl ID : ENSPSNG00000016884
Gene Symbol: CTSC
3 Cross references
233 Possible Orthologues:

Cathepsin K

Ensembl ID : ENSPSNG00000002537
Gene Symbol: CTSK
3 Cross references
240 Possible Orthologues:

Cathepsin S

Ensembl ID : ENSPSNG00000002456
Gene Symbol: CTSS
1 Cross references
269 Possible Orthologues:

Cell Division Cycle 7

Ensembl ID : ENSPSNG00000014009
Gene Symbol: CDC7
3 Cross references
208 Possible Orthologues:

Checkpoint Kinase 1

Ensembl ID : ENSPSNG00000012682
Gene Symbol: CHEK1
3 Cross references
177 Possible Orthologues:

Checkpoint Kinase 2

Ensembl ID : ENSPSNG00000010649
Gene Symbol: CHEK2
3 Cross references
205 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).